ADH5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.521000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.041800E-01
Normal-vs-Stage2
8.831800E-01
Normal-vs-Stage3
4.555800E-01
Normal-vs-Stage4
5.272600E-01
Stage1-vs-Stage2
4.828000E-01
Stage1-vs-Stage3
7.823200E-01
Stage1-vs-Stage4
2.418400E-01
Stage2-vs-Stage3
3.335600E-01
Stage2-vs-Stage4
1.594000E-01
Stage3-vs-Stage4
2.310800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.764600E-01
Normal-vs-AfricanAmerican
9.272200E-01
Normal-vs-Asian
3.744600E-01
Caucasian-vs-AfricanAmerican
9.248600E-01
Caucasian-vs-Asian
1.925840E-01
AfricanAmerican-vs-Asian
3.119600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.008000E-01
Normal-vs-Female
9.177200E-01
Male-vs-Female
5.266800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.001600E-01
Normal-vs-Age(41-60Yrs)
8.016600E-01
Normal-vs-Age(61-80Yrs)
7.200000E-01
Normal-vs-Age(81-100Yrs)
7.653000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.674400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.009600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.034600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.476500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.027400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.356600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.473000E-01
Normal-vs-Daily Drinker
4.904400E-01
Normal-vs-Weekly Drinker
5.833400E-01
Normal-vs-Occasional Drinker
7.922800E-01
Normal-vs-Social Drinker
8.864800E-01
Non Drinker-vs-Daily Drinker
8.715200E-01
Non Drinker-vs-Weekly Drinker
6.891000E-01
Non Drinker-vs-Occasional Drinker
4.456200E-02
Non Drinker-vs-Social Drinker
1.054210E-01
Daily Drinker-vs-Weekly Drinker
8.022200E-01
Daily Drinker-vs-Occasional Drinker
7.569600E-02
Daily Drinker-vs-Social Drinker
1.585010E-01
Weekly Drinker-vs-Occasional Drinker
1.713420E-01
Weekly Drinker-vs-Social Drinker
2.928000E-01
Occasional Drinker-vs-Social Drinker
8.796200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.263800E-01
Normal-vs-Grade 2
6.104600E-01
Normal-vs-Grade 3
1.279980E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.442700E-03
Grade 1-vs-Grade 3
1.262230E-02
Grade 1-vs-Grade 4
5.263800E-01
Grade 2-vs-Grade 3
7.262800E-01
Grade 2-vs-Grade 4
6.104600E-01
Grade 3-vs-Grade 4
1.279980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.130200E-01
Normal-vs-NonDiabetic
8.128800E-01
Diabetic-vs-NonDiabetic
3.822400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.262400E-01
Normal-vs-NoPancreatitis
7.401600E-01
Pancreatitis-vs-NoPancreatitis
1.692220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.330000E-01
Normal-vs-N1
9.092600E-01
N0-vs-N1
6.449800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.729600E-01
Normal-vs-TP53-NonMutant
8.073400E-01
TP53-Mutant-vs-TP53-NonMutant
2.890200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
